Biomatrix (BXM) Looking Great Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dalroi who wrote (557)	3/20/2000 2:23:00 PM
From: scaram(o)uche	Read Replies (1) of 569

cbs.marketwatch.com Screamers Collateral Therapeutics rises on upbeat study By Stephanie O'Brien, CBS MarketWatch Last Update: 2:04 PM ET Mar 20, 2000 NewsWatch NEW YORK (CBS.MW) -- Shares of Collateral Therapeutics rose more than 60 percent Monday after the company said its Generx drug was safe and effective in an early stage trial. Shares of Collateral Therapeutics (CLTX: news, msgs) rose 17 3/8 to 43 1/8 in recent trading. Results of Collateral's Phase I/II trial of Generx in patients with chest pain showed that the drug was safe, well-tolerated and effective at multiple doses, the company said. (snip)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next